Erratum to: PREDICT: A new UK prognostic model that predicts survival following surgery for invasive breast cancer Breast Cancer [Research, 12, (2010)(401)] DOI: 10.1186/bcr2464;PREDICT: A new UK prognostic model that predicts survival following surgery for invasive breast cancer

Breast Cancer Research

Volumn 12, Issue 1, 2010, Pages

  Wishart, Gordon C ^a   Azzato, Elizabeth M ^b,c   Greenberg, David C ^d   Rashbass, Jem ^d   Kearins, Olive ^e   Lawrence, Gill ^e   Caldas, Carlos ^a,f   Pharoah, Paul D P ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Eastern Cancer Registration and Information Centre (ECRIC)   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; UNITED KINGDOM; BREAST TUMOR; CANCER REGISTRY; MIDDLE AGED; MORTALITY; REGISTER; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTORS, ESTROGEN; REGISTRIES; SEER PROGRAM;

EID: 77953238815     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2480     Document Type: Erratum

References (15)

1. Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC. A prognostic index in primary breast cancer. Br J Cancer 1982, 45:361-366. 2010939, 7073932.
2. Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, Hinton CP, Blamey RW, Haybittle JL. Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987, 56:489-492. 2001834, 3689666.
3. D'Eredita G, Giardina C, Martellotta M, Natale T, Ferrarese F. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long term follow-up that were treated in a single institution. Eur J Cancer 2001, 37:591-596. 10.1016/S0959-8049(00)00435-4, 11290434.
4. Blamey RW, Ellis IO, Pinder SE, Lee AH, Macmillan RD, Morgan DA, Robertson JF, Mitchell MJ, Ball GR, Haybitle JL, Elston CW. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer 2007, 43:1548-1555. 10.1016/j.ejca.2007.01.016, 17321736.
5. Blamey RW, Pinder SE, Ball GR, Ellis IO, Elston CW, Mitchell MJ, Haybittle J. Reading the prognosis of the individual with breast cancer. Eur J Cancer 2007, 43:1545-1547. 10.1016/j.ejca.2007.04.017, 17544653.
6. Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, Parker HL. Computer Program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001, 19:980-991.
7. Early Breast Cancer Trialists' Collaborative Group Tamoxifen for early breast cancer: An overview of randomized trials. Lancet 1998, 351:1451-1467. 10.1016/S0140-6736(97)11423-4, 9605801, Early Breast Cancer Trialists' Collaborative Group.
8. Early Breast Cancer Trialists' Collaborative Group Polychemotherapy for early breast cancer: An overview of randomized trials. Lancet 1998, 352:930-942. 10.1016/S0140-6736(98)03301-7, 9752815, Early Breast Cancer Trialists' Collaborative Group.
9. Olivoto IA, Bajdik CD, Ravdin PM, Speers CH, Coldman AJ, Norris BD, Davis GJ, Chia SK, Gelmon KA. Population-based validation of the prognostic model Adjuvant! for early breast cancer. J Clin Oncol 2005, 23:2716-2725. 10.1200/JCO.2005.06.178, 15837986.
10. Campbell HE, Taylor MA, Harris AL, Gray AM. An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom. Br J Cancer 2009, 101:1074-1084. 10.1038/sj.bjc.6605283, 19724274.
11. Azzato EM, Greenberg D, Shah M, Blows F, Driver KE, Caporaso NE, Pharoah PDP. Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?. BJC 2009, 100:1806-1811.
12. May S, Hosmer DW. A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Analysis 1998, 4:109-120. 10.1023/A:1009612305785, 9658770.
13. Joensuu H, Lehtimaki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, Anttila A, Lundin M, Isola J, Lundin J. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 2004, 292:1064-1073. 10.1001/jama.292.9.1064, 15339900.
14. Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 2005, 97:1195-1203.
15. Wishart GC, Greenberg DC, Britton PD, Chou P, Brown CH, Purushotham AD, Duffy SW. Screen-detected versus symptomatic breast cancer: is improved survival due to stage migration alone?. Br J Cancer 2008, 98:1741-1744. 10.1038/sj.bjc.6604368, 2410118, 18506175.